Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,308 public trials 520 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Recruiting

A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)

NCT07137494

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering at Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering at Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Study of Automated Axicabtagene Ciloleucel for R/R Large B-cell Lymphoma.

NCT07606937

Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • The Frist Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
  • Shanghai Jiaotong University School of Medicine Ruijin Hospital Shanghai, Shanghai Municipality, China
View Trial Details
Recruiting

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

NCT04777994

Conditions
Adenocarcinoma, Advanced Solid Tumor Cancer, Bronchial Neoplasms, +29 more
Locations
  • University of Arizona Cancer Center - Tucson /ID# 262698 Tucson, Arizona, United States
  • Yale University School of Medicine /ID# 225707 New Haven, Connecticut, United States
  • Johns Hopkins Hospital /ID# 254056 Baltimore, Maryland, United States
  • Beth Israel Deaconess Medical Center /ID# 252009 Boston, Massachusetts, United States
View all 30 locations
View Trial Details
Recruiting

A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma

NCT07085338

Conditions
Disease Attributes, Neuroblastoma Recurrent, Pathologic Processes, +2 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Children's Hospital of Colorado Colorado Springs, Colorado, United States
  • Motts Childrens Hospital Ann Arbor, Michigan, United States
  • St. Jude Children's Research Hospital Memphis, Tennessee, United States
View Trial Details
Recruiting

Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients.

NCT04915248

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • A.O. Universitaria Ospedali Riuniti - Ospedale Umberto I Di Ancona Ancona, Italy
  • Aviano - IRCCS Centro di Riferimento Oncologico di Aviano - Divisione di Oncologia e dei Tumori immuto-correlati Aviano, Italy
  • A.O. Spedali Civili di Brescia - Ematologia Brescia, Italy
  • Azienda Ospedaliera Universitaria Careggi - Unità funzionale di Ematologia Florence, Italy
View all 18 locations
View Trial Details

Related conditions